1. Sim CS. Abdominal Ultrasound. Seoul:Yeo Mun Gak. 2002:268.

2. Liver System Association of Internal Medicine. Liver System of Internal Medicine. 5th ed. Seoul:Nado; 2013:38, 321-5.

3. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221-31.

4. Kim SY. The Association of Nonalcoholic Fatty Liver Disease with Metabolic Syndrome [dissertation]. Seoul: Ewha Womans Univ.;2006.

5. Caturelli E, Squillatne MM, Andriulli A, Rapaccini GL. Hypoechoic lesions in the ‘bright liver’ : A reliable indicator of fatty change. A prospective study. J Gastroenterol Hepatol. 1992;7:469-72.

6. Joseph AE, Saverymuttu SH, al Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol. 1991;43(1):26-31.

7. Hong MU, Hong H. Practical Chinise Medicine of Digestive Disease. 1st ed. Tianjin:Tianjin Science & Technology Translation & Publishing CO.. 1994:235.

8. Scatarige JC, Scott WW, Donovan PJ, Siegelman SS, Sanders RC. Fatty infiltration of the liver: ultrasonographic and computerized tomographic correlation. J Ultrasound Med. 1984;3:9-14.

9. Kim HK, Gwon YO, Kim JY, Gwak KS, Choi RH, Jeong JM, et al. Comparatives Studty of Serum Transaminase Level and Liver Biopsy Finding in Fatty Liver. Journal of Korean Medical Association. 1988;31(1):79-84.

10. Kim SH, Kang DH, Lee SH, Yun CH. Causes of Fatty Liver Diagnosed by Abdominal Ultrasonography. Korean J Fam Med. 1995;16(11):785-794.

11. Cho KH, Hong MH, Yu HD, Lee TH, Cho AK, Park YK, et al. Clinical Significance of Fatty Liver diagnosed by Abdominal Ultrasonography. Korean J Fam Med. 1993;14(11):734-742.

12. Im CS, Kim SS. Risk Factors Associated with Metabolic Syndrome in Ultrasonographic Fatty Liver. Korean J Obes. 2008;17(3):124-131.

13. Hultcrantz R, Gabrielsson N. Patients with persistent elevation of aminotransferases:investigation with ultrasonography, radionuclide imaging and liver biopsy. J Intern Med. 1993;233:7-12.

14. Fishbein MH, Gardner KG, Potter CJ, Schmalbrock P, Smith MA. Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging. 1997;15:287-93.

15. Mclane J. Analysis of common side effects of isotretinoin. J Am Acad Dermatol. 2001;45:S188-94.

16. Rodondi N1, Darioli R, Ramelet AA, Hohl D, Lenain V, Perdrix J, et al. “High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study.” Ann Intern Med. 136(2002): 582-9.

17. McCarter TL, Chen YK. “Marked hyperlipidemia and pancreatitis associated with isotretinoin therapy.” Am J Gastroenterol. 1992;87:1855-8.

18. Wysowski DK, Pitts M, Beitz J. “An analysis of reports of depression and suicide in patients treated with isotretinoin.” J Am Acad Dermatol. 2001;45:515-9.

19. Ryu KJ, Kim JH, Han C, Park JH, Kwon SR. A Case Report of Panic Disorder with Functional Gastrointestinal Disturbance. J of Oriental Neuropsychiatry. 2009;20(2):187-196.

20. Oh KC. A Clinical report on Panic Disorder with Nausea treated by Shihosogantang-gami. J of the Korea Institute of Oriental Medical Diagnostics. 2012;16(3):59-68.

21. Lee SR, Ryu HY. Effects of Ondamtang, Samulansintang and Shihosogansan Water Extract on the Obesity and Stress. J of Oriental Neuropsychiatry. 1992;3(1):25-45.